Triple-negative breast cancer risk in women is defined by the defect of estrogen signaling: preventive and therapeutic implications
Zsuzsanna Suba National Institute of Oncology, Surgical and Molecular Tumor Pathology Centre, Budapest, Hungary Abstract: Epidemiologic studies strongly support that triple-negative breast cancers (TNBCs) may be distinct entities as compared with estrogen receptor (ER)+ tumors, suggesting that the...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2014-01-01
|
| Series: | OncoTargets and Therapy |
| Online Access: | http://www.dovepress.com/triple-negative-breast-cancer-risk-in-women-is-defined-by-the-defect-o-a15606 |